摘要
目的评价前列腺素E1联合喘可治雾化吸入治疗慢性阻塞性肺疾病急性加重期（AECOPD）的临床疗效。方法选择我院2013年4月～2015年3月收治的AECOPD患者110例,随机分为治疗组和对照组,每组55例,在常规治疗的基础上,对照组加用糜蛋白酶、庆大霉素雾化吸入治疗,治疗组加用前列腺素E1联合喘可治雾化吸入治疗,比较两组的临床疗效。结果治疗组总有效率为92.73%,优于对照组的78.18%,差异有统计学意义（P〈0.05）。结论在常规治疗方法的基础上加用前列腺素E1与喘可治雾化吸入治疗AECOPD,可改善患者的血气分析和肺功能指标,临床疗效比较显著。
Objective Evaluation of the clinical efficacy of prostaglandin E1 combined with chuankezhi aerosol inhalation for the treatment of acute exacerbation of chronic obstructive pulmonary disease（AECOPD）. Methods From April 2013 to March 2015,110 cases of patients with AECOPD in our hospital were randomly divided into treatment group and control group,55 cases in each group. Based on conventional treatment,control group was treated with atomization inhalation of chymotrypsin,gentamicin,treatment group was treated with prostaglandin E1 combined with chuankezhi inhalation,to compare the clinical efficacy about two groups. Results The total effective rate in treatment group was 92.73%,which was significantly higher than 78.18% in control group,the difference was statistically significant（P〈0.05）. Conclusion Conventional treatment combined with prostaglandin E1 and chuankezhi aerosol inhalation for AECOPD has significant effect on improving the patient＇s the index of arterial blood gas analysis and pulmonary function.
出处
《中国卫生标准管理》
2016年第9期126-128,共3页
China Health Standard Management
关键词
慢性阻塞性肺疾病
前列腺素E1
喘可治
疗效
Chronic obstructive pulmonary disease
Prostaglandin E1
Chuankezhi
Effect
